ClinConnect ClinConnect Logo
Search / Trial NCT06373393

SPIRIT: Study of the Patency of Spinal aRteries After the STABILISE Technique

Launched by ASSOCIACAO PARA INVESTIGACAO E DESENVOLVIMENTO DA FACULDADE DE MEDICINA - CETERA · Apr 16, 2024

Trial Information

Current as of July 09, 2025

Enrolling by invitation

Keywords

Aortic Dissection Stabilise Spinal Cord Ischemia Bare Stent Stent Graft Endovascular Repair

ClinConnect Summary

BACKGROUND AND STUDY INTRODUCTION

Endovascular treatment emerged over the last decade as the standard of care for complicated acute type B aortic dissection and the first step is usually the deployment of a thoracic endograft (TEVAR) aiming to cover the entry tear. TEVAR may be enough to fix malperfusion syndromes but is frequently associated with late aortic dilatation and unfavorable remodeling \[1,2\]. The failure of simple TEVAR to solve malperfusion syndromes led to the development of adjunctive techniques like direct stenting of the occluded arteries, fenestration of the lamella or t...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients with type B dissection treated according to the STABILISE technique
  • Exclusion Criteria:
  • Aortic rupture.

About Associacao Para Investigacao E Desenvolvimento Da Faculdade De Medicina Cetera

The Associação para Investigação e Desenvolvimento da Faculdade de Medicina - Cetera is a distinguished clinical trial sponsor dedicated to advancing medical research and innovation. Affiliated with a leading medical faculty, Cetera focuses on the design, execution, and management of clinical studies that aim to enhance healthcare outcomes. With a commitment to ethical standards and scientific rigor, the organization collaborates with healthcare professionals, researchers, and institutions to facilitate groundbreaking discoveries and translate findings into effective treatments. Through its robust infrastructure and expertise, Cetera plays a pivotal role in driving forward the frontiers of medical knowledge and patient care.

Locations

Lisbon, , Portugal

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported